A system and method to selectively illuminate (part of) an infant during phototherapy uses an array of collimators and a set of light sources to control impingement of electromagnetic radiation on the infant.

A personal therapy compartment includes a base of size to receive a human patient. The compartment includes a bed in the base said bed being made of a light transmissive material. An array of lights mounted is below the bed to transmit light onto a body supported on the bed. A control panel controls at least the wavelength, intensity and pulsation of the light.

A phototherapy device includes at least one flexible sheet that has first and second electrical conduction layers, an electrical insulation layer between the first and second electrical conduction layers, and light emitting diodes (LEDs) disposed along the electrical insulation layer between the first and second electrical conduction layers. The first electrical conduction layer includes a conductive polymer. The electrical conduction layers and the LEDs are part of an electrical circuit in which the LEDs illuminate responsive to an electrical input. There is at least one meter to measure an electrical property of the electrical circuit. A control module is in communication with the meter and configured to adjust the electrical input responsive to the electrical property of the electrical circuit.

A portable, personal therapy chamber for provision of radiation therapy. The therapy chamber includes a pair of telescopically positionable units that are lightweight and easily portable by a single user. The therapy chamber is configured for use by a single person lying generally prone on a surface. The units are formed from a plurality of pivotably coupled panels that are foldable in a first direction to a rolled up, tube-like storage configuration and unfoldable in a second direction to an arched formation or use configuration. The units, in the use configuration, are disposed to overlie the user and include a plurality of emitters that direct infrared energy toward the user's body.

A phototherapy system having sensor(s) for detecting parameters associated with light generation by a light source and circuitry for modulating the light source based on the detected parameters. Also, a phototherapy system having a light guide interfacing with a light source at a connection point, an ambient light sensor, a connector light sensor for detecting (at the connection point) ambient light received by a light emitting pad that is directed into the light guide, and circuitry for determining whether the light guide is correctly connected to the light source based on a difference between the output of the ambient light source and the connector light sensor. Further, a phototherapy system including a light emitting pad having an identification tag and circuitry that modulates a light source based on the identification tag. Additionally, a phototherapy system including a casing encapsulating multiple light emitters and a light emitting pad.

The invention relates to an irradiation module for use in a device (1) for irradiation with medical and cosmetic radiation, comprising a plurality of LEDs arranged on a carrier. The invention also relates to a device for irradiating a user (10) with medical and cosmetic radiation, comprising a plurality of irradiation modules (40) for irradiation with medical and cosmetic radiation, which modules are accommodated in a housing part (20; 30). The invention further relates to a method for irradiating a user (10) with medical and cosmetic radiation, comprising a plurality of irradiation modules (40) for irradiation with medical and cosmetic radiation, which modules are selected from the group comprising fluorescent tubes, LEDs, organic LEDs, and high-pressure lamps. In order to provide an irradiation module and a device and a method with which improved irradiation results can be achieved according to the invention, a first group of first LEDs, which emits radiation within the UVA spectrum, and a second group of second LEDs, which emits radiation within the UVB spectrum, are arranged on the carrier.

The invention relates to a device for acting on at least parts of the body of a user, in particular with medical-cosmetic radiation and/or by mechanical influence, comprising means for acting (22, 23) on the human body, which have adjustable operating parameters, and a controller (38), which is connected to the means for acting (22, 23) and sets the operating parameters. A device for acting on at least parts of the body of a user, which device can be set to the needs of the user, in particular even during operation, is provided according to the invention in that at least one microphone is provided, by means of which voice inputs of the user for controlling the operating parameters can be captured, and in that the microphone is connected to an evaluation unit, which converts voice inputs captured by the microphone into control commands for the means for acting (22, 23).

Devices and methods for light therapy wherein a device for delivery of light therapy comprising a light emitting pad member (e.g., a blanket or other body cover) is positionable over all, substantially all or at least half of a subject's body and operable to deliver light therapy thereto.

A self-contained, hyperthermic conditioning unit and selectively controllable environment for exercising. The unit comprises a base portion having a bed therein and a removable cover connected to the base portion to enclose a personal compartment within the unit. One or more heating elements provide heat to the personal compartment and one more pieces of physical exercise equipment are provided within the personal compartment.

A therapy, treatment and process for inactivating and/or killing COVID-19 (Corona Virus Disease 2019) is provided, including a low-dose, full body, Ultraviolet A1 (UV-A1, 360-400 nm) photon therapy, wherein the UV-A1 photon therapy activates singlet oxygen (.sup.1O.sub.2), which inactivates and/or kills COVID-19. UV-A1 therapy of the present invention can also be used to help alleviate symptoms and secondary illnesses caused by COVID-19. UV-A1 therapy of the present invention can also be used to help alleviate and treat pre-existing conditions of people that are also suffering from COVID-19 and worsened by COVID-19.